Source comparison
Tolerance to CJC-1295 No DAC Cycling: Comparison Table
8/4 Protocol 8 weeks 4 weeks 85–90% baseline receptor density Short intervention studies; multiple cycles per year Adequate recovery but limited active phase. Works best for researchers prioritising cycle frequency over sustained elevation 10/5 Protocol 10 wee
This comparison does not assign a generated winner or score.
- 8/4 Protocol
- 8 weeks
- 4 weeks
- 85–90% baseline receptor density
- Short intervention studies; multiple cycles per year
- Adequate recovery but limited active phase. Works best for researchers prioritising cycle frequency over sustained elevation
- 10/5 Protocol
- 10 weeks
- 5 weeks
- 90–95% baseline receptor density
- Balanced intervention and recovery timelines
- Optimal balance between sustained GH elevation and receptor preservation. Most versatile structure for multi-cycle research
- 12/6 Protocol
- 12 weeks
- 6 weeks
- 95% baseline receptor density
- Extended single-cycle studies; lean mass research
- Maximum active phase before tolerance significantly limits returns. Six-week washout ensures full receptor reset for next cycle
- Continuous (no cycling)
- Indefinite
- None
- 50–60% baseline receptor density by week 12
- Not recommended for sustained protocols
- Receptor adaptation compresses GH response to marginal levels within 12–16 weeks. Suitable only for short-term proof-of-concept work
- 6/3 Protocol
- 3 weeks
- 70–80% baseline receptor density
- Rapid-cycle exploratory research
- Insufficient washout for full receptor recovery. Each subsequent cycle starts with pre-adapted receptors and diminishing returns accelerate